I-3-(Hydroxymethyl)phenylboronic Acid CAS 87199-15-3 Ubunyulu>99.5% (HPLC) Umgangatho ophezulu weFactory
Ubonelelo loMvelisi ngoMgangatho oPhezulu, iMveliso yoRhwebo
Igama leKhemikhali: 3-(Hydroxymethyl)phenylboronic Acid
CAS: 87199-15-3
Igama leMchiza | 3-(Hydroxymethyl)phenylboronic Acid |
Izithethantonye | 3-(Hydroxymethyl)benzeneboronic Acid |
Inombolo yeCAS | 87199-15-3 |
Inombolo yeCAT | RF-PI1296 |
Ubume beStokhwe | Kwi-Stock, iMveliso yeMveliso ukuya kwiiToni ezingama-25 / ngenyanga |
Ifomula yeemolekyuli | C7H9BO3 |
Ubunzima beMolekyuli | 151.96 |
Indawo yokunyibilika | 95.0~99.0℃ (ilayiti.) |
Ukunyibilika | Inyibilika kwiMethanol;Inyibilika kancinane emanzini |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Mhlophe ukuya kwi-Off-White Powder |
Ubunyulu / Indlela yokuHlalutya | >99.5% (HPLC) |
Ilahleko ekomisweni | <0.50% |
Intsalela kwi-Ignition | ≤0.20% |
Ukungacoceki Okukodwa | <0.20% |
Ukungcola ngokupheleleyo | <0.50% |
Iintsimbi ezinzima (njenge Pb) | <20ppm |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | AbaPhakathi bamayeza |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.
![1](https://www.ruifuchemical.com/uploads/15.jpg)
![](https://www.ruifuchemical.com/uploads/23.jpg)
I-3-(Hydroxymethyl) phenylboronic Acid (CAS: 87199-15-3), i-Reactant esetyenziselwa i-Suzuki-Miyaura Cross Coupling Reaction, i-copper-mediated trifluoromethylation, i-copper-catalyzed transformations esuka kwi-arylboronic acid emanzini, i-Mitsunobu, i-Suzukis kunye ne-amidation reaction. ihydroxyphenylamino bromopyrazinecarboxylate.I-Reactant ebandakanyekayo ekudityanisweni kweemolekyuli zebhayoloji ezisebenzayo eziquka iMycobacterium tuberculosis H37Rv chorismate mutase inhibitors ngeSuzuki coupling reactions, HIV protease inhibitors ngomsebenzi we-antiviral ngokuchasene neentsholongwane ezinganyangekiyo ngamachiza, iPyrrole derivatives ukuze isetyenziswe njenge PDE4B inhibitors.